Adamantyl-THPINACA

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Project Osprey (talk | contribs) at 10:16, 9 December 2015 (noting CAS). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Adamantyl-THPINACA
Identifiers
  • N-(2-adamantyl)-1-(tetrahydropyran-4-ylmethyl)indazole-3-carboxamide
CAS Number
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC24H31N3O2
Molar mass393.53 g/mol g·mol−1
3D model (JSmol)
  • C12C(C3CC(CC(C1)C3)C2)NC(=O)C2=NN(C3=CC=CC=C23)CC2CCOCC2
  • InChI=1/C24H31N3O2/c28-24(25-22-18-10-16-9-17(12-18)13-19(22)11-16)23-20-3-1-2-4-21(20)27(26-23)14-15-5-7-29-8-6-15/h1-4,15-19,22H,5-14H2,(H,25,28)/f/h25H
  • Key:XFZLBNDGZVRJNJ-UHFFFAOYSA-N

ADAMANTYL-THPINACA is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor and has been sold online as a designer drug. It was first discovered in Slovenia as part of a seizure of 746 grams of white powder and 2 kilograms of brown/green plant material in October 2014.[1]

Legal status

ADAMANTYL-THPINACA is banned in Sweden.[2]

See also

References

  1. ^ "Muuntohuumeiden esiintyvyys 2015" (PDF). Finnish Medicines Agency. 7 May 2015. Retrieved 24 July 2015.
  2. ^ "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 24 July 2015.